Glucagon Signaling in Obesity and Type 2 Diabetes
Welcome to this webinar on glucagon signaling in obesity and type 2 diabetes with Dr. Jennifer Stern from the University of Arizona.
During the webinar, Dr. Stern talks about the metabolic actions of glucagon and why blockage of the glucagon receptor is beneficial for lowering glucose levels. Moreover, discusses the glucagon: insulin ratio and what additional information it gives in T2DM, compared with measuring the two hormones individually.
Watch the webinar Glucagon Signaling in Obesity and Type 2 Diabetes